Document is current
Any future updates will be listed below
-
Authors
Richman, Juliet https://orcid.org/0000-0001-7414-9471
Schuster, Gene
Buus, Richard
Lopez-Knowles, Elena
Dowsett, Mitch
-
Funding
Funding for this research was provided by:
Cridlan Fund
Breast Cancer Now
- License Information
-
More Information
Article History
Received: 3 January 2024
Accepted: 22 March 2024
First Online: 6 May 2024
Declarations
:
: R Buus declares employment and stock ownership of NanoString Technologies.
: The protocol was submitted to and approved by the Royal Marsden Hospital Committee for Clinical Research (CCR No. 4984). HRA approval was sought and granted from HRA and Health Care Research Wales. Research ethics approval was sought and granted from the Health and Social Care Research Ethics Committee (REC ref 18/NI/0227).
